GERRESHEIMER AG (GXI.DE) Fundamental Analysis & Valuation

FRA:GXI • DE000A0LD6E6

18.83 EUR
+0.18 (+0.97%)
Last: Mar 12, 2026, 11:55 AM

This GXI.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

GXI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 22 industry peers in the Life Sciences Tools & Services industry. GXI may be in some trouble as it scores bad on both profitability and health. GXI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. GXI.DE Profitability Analysis

1.1 Basic Checks

  • GXI had positive earnings in the past year.
  • GXI had a positive operating cash flow in the past year.
  • GXI had positive earnings in each of the past 5 years.
  • Each year in the past 5 years GXI had a positive operating cash flow.
GXI.DE Yearly Net Income VS EBIT VS OCF VS FCFGXI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • GXI has a worse Return On Assets (0.50%) than 81.82% of its industry peers.
  • GXI has a Return On Equity of 1.67%. This is in the lower half of the industry: GXI underperforms 77.27% of its industry peers.
  • GXI has a worse Return On Invested Capital (2.79%) than 81.82% of its industry peers.
  • GXI had an Average Return On Invested Capital over the past 3 years of 6.14%. This is significantly below the industry average of 14.22%.
Industry RankSector Rank
ROA 0.5%
ROE 1.67%
ROIC 2.79%
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
GXI.DE Yearly ROA, ROE, ROICGXI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • GXI has a Profit Margin of 1.04%. This is amonst the worse of the industry: GXI underperforms 81.82% of its industry peers.
  • In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
  • GXI has a Operating Margin of 5.99%. This is amonst the worse of the industry: GXI underperforms 81.82% of its industry peers.
  • GXI's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 26.89%, GXI is doing worse than 77.27% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
Industry RankSector Rank
OM 5.99%
PM (TTM) 1.04%
GM 26.89%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
GXI.DE Yearly Profit, Operating, Gross MarginsGXI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

0

2. GXI.DE Health Analysis

2.1 Basic Checks

  • GXI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, GXI has about the same amount of shares outstanding.
  • The number of shares outstanding for GXI has been increased compared to 5 years ago.
  • GXI has a worse debt/assets ratio than last year.
GXI.DE Yearly Shares OutstandingGXI.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GXI.DE Yearly Total Debt VS Total AssetsGXI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • GXI has an Altman-Z score of 0.91. This is a bad value and indicates that GXI is not financially healthy and even has some risk of bankruptcy.
  • GXI has a Altman-Z score of 0.91. This is amonst the worse of the industry: GXI underperforms 81.82% of its industry peers.
  • GXI has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of GXI (1.22) is worse than 68.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACC0.37
WACC7.62%
GXI.DE Yearly LT Debt VS Equity VS FCFGXI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that GXI may have some problems paying its short term obligations.
  • With a Current ratio value of 0.98, GXI is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.52 indicates that GXI may have some problems paying its short term obligations.
  • GXI's Quick ratio of 0.52 is on the low side compared to the rest of the industry. GXI is outperformed by 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.52
GXI.DE Yearly Current Assets VS Current LiabilitesGXI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. GXI.DE Growth Analysis

3.1 Past

  • The earnings per share for GXI have decreased strongly by -19.08% in the last year.
  • The Earnings Per Share has been decreasing by -8.23% on average over the past years.
  • Looking at the last year, GXI shows a quite strong growth in Revenue. The Revenue has grown by 11.83% in the last year.
  • Measured over the past years, GXI shows a small growth in Revenue. The Revenue has been growing by 7.90% on average per year.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%

3.2 Future

  • Based on estimates for the next years, GXI will show a small growth in Earnings Per Share. The EPS will grow by 3.46% on average per year.
  • Based on estimates for the next years, GXI will show a small growth in Revenue. The Revenue will grow by 6.99% on average per year.
EPS Next Y-54.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
EPS Next 5Y3.46%
Revenue Next Year12.69%
Revenue Next 2Y7.49%
Revenue Next 3Y6.85%
Revenue Next 5Y6.99%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GXI.DE Yearly Revenue VS EstimatesGXI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
GXI.DE Yearly EPS VS EstimatesGXI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

6

4. GXI.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.10 indicates a rather cheap valuation of GXI.
  • GXI's Price/Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.15, GXI is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 7.19, the valuation of GXI can be described as very cheap.
  • GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.27. GXI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.1
Fwd PE 7.19
GXI.DE Price Earnings VS Forward Price EarningsGXI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GXI indicates a rather cheap valuation: GXI is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.72
GXI.DE Per share dataGXI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • GXI's earnings are expected to decrease with -8.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%

4

5. GXI.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.22%, GXI is not a good candidate for dividend investing.
  • The stock price of GXI dropped by -33.49% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 0.45, GXI has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, GXI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.22%

5.2 History

  • The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
GXI.DE Yearly Dividends per shareGXI.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • GXI pays out 10.12% of its income as dividend. This is a sustainable payout ratio.
  • GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP10.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
GXI.DE Yearly Income VS Free CF VS DividendGXI.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
GXI.DE Dividend Payout.GXI.DE Dividend Payout, showing the Payout Ratio.GXI.DE Dividend Payout.PayoutRetained Earnings

GXI.DE Fundamentals: All Metrics, Ratios and Statistics

GERRESHEIMER AG

FRA:GXI (3/12/2026, 11:55:04 AM)

18.83

+0.18 (+0.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-26
Earnings (Next)04-16
Inst Owners91.76%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap650.39M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts53.04
Price Target34.62 (83.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.22%
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-9.89%
PT rev (3m)-10.63%
EPS NQ rev (1m)-241.13%
EPS NQ rev (3m)-211.42%
EPS NY rev (1m)-25.78%
EPS NY rev (3m)-30.66%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE 5.1
Fwd PE 7.19
P/S 0.29
P/FCF N/A
P/OCF 2.56
P/B 0.46
P/tB N/A
EV/EBITDA 6.72
EPS(TTM)3.69
EY19.6%
EPS(NY)2.62
Fwd EY13.91%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY38.99%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
Industry RankSector Rank
ROA 0.5%
ROE 1.67%
ROCE 3.76%
ROIC 2.79%
ROICexc 2.93%
ROICexgc 5.89%
OM 5.99%
PM (TTM) 1.04%
GM 26.89%
FCFM N/A
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA 4.4
Cap/Depr 134.54%
Cap/Sales 15.12%
Interest Coverage 1.65
Cash Conversion 65.42%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.52
Altman-Z 0.91
F-Score4
WACC7.62%
ROIC/WACC0.37
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-54.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
EPS Next 5Y3.46%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year12.69%
Revenue Next 2Y7.49%
Revenue Next 3Y6.85%
Revenue Next 5Y6.99%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year81.16%
EBIT Next 3Y29.65%
EBIT Next 5Y20.08%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%

GERRESHEIMER AG / GXI.DE FAQ

What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.


What is the valuation status for GXI stock?

ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.


How profitable is GERRESHEIMER AG (GXI.DE) stock?

GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.


What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?

The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -54.12% in the next year.


How sustainable is the dividend of GERRESHEIMER AG (GXI.DE) stock?

The dividend rating of GERRESHEIMER AG (GXI.DE) is 4 / 10 and the dividend payout ratio is 10.12%.